Just a question. Do you think shorts have a hint that there is not a good news coming and that why they so confident in shorting shares. I saw some companies before results come in had increased short share count. Then reported bad results. By they I am long 30000 shares

Look at that company market cap even after 1000% increase. Everything increase in share price depends on outstanding shares count.

I think there was dates confusion

So why do you still own the shares of company that failed?

TLD was never ever announced on conferences or journals. TLD was always announced trough press releases but details of trials were announced at closest medical conferences. If there is no close medical conferences happening any time soon then details of trial are written in reputable medical journal.

Look at Avxl today. They reported phase 1-2 trial results. They way they put out announcement.

I agree. All bio companies I invested before never announce details with TLD. All they do is announce if it met primary or secondary endpoints and numbers related to it. Usually details being revealed at presentations at follow conferences. By the way if I remember it right from data lock to announcement something it takes from couple of weeks to month and a half depending of how complicated and how long trial was. Just my personal opinion.

Don’t listen to him. He been doing that on Relief pharm board. Saying same thing like broken record. He thinks we are kids to listen his nonsense

Just looked at My dads 2021 Cigna Medicare prescription plan. Vacsepa on tier 3. But Cigna has 6-tier. Tier1: Preferred Genetic. Tier2 Generic. Tier3 Preferred Brand. Tier4 Non-Preferred. Tier5 Specialty. Tier6 Select care drugs. By the way could not find Lovaza at all weird.

From Markman:”
Importantly, the Court found that these promotional materials induced infringement of the GSK patent covering its CHF indication not because they actively and affirmatively encouraged doctors to prescribe Teva’s generic for the CHF indication (the indication that had been carved out of Teva’s label). Instead, the Court found that inducement existed simply because the promotional materials failed to expressly specify that Teva’s generic drug was not indicated for the CHF indication.

I wonder if genetics will launch. Do they have to emphasize on their label that drug is not for reducing cardiovascular ?

FDA Sets Goals That May Put Vaccine Out of Reach Before Vote https://www.bloomberg.com/news/articles/2020-10-06/fda-to-demand-two-months-safety-data-expert-review-for-vaccine

September 17: List of Outstanding Issues (LoOI)
- December 23*: Response to Day 180 LoOI, September 17 (Amarin will have three months to answer the LoOI.)
- January 28: Day 210 Opinion by EMA / recommendation of approval
- April 5: EU Commission Decision / formal approval (based on Day 210 Opinion by EMA, January 28)

(ii) “shortest” EMA timetable (after clock-stop for responses)

- September 17: Day 180 List of Outstanding Issues (LoOI)
- October 13*: Response to Day 180 LoOI, September 17
- November (9-)12: Day 210 Opinion by EMA / recommendation of approval
- January 18: Commission Decision / formal approval (based on Day 210 Opinion by EMA, November 12)

(iii) “shortest” EMA timetable (after immediate responses**)

- September 17: Day 180 List of Outstanding Issues (LoOI)
- September 22*: Response to Day 180 LoOI, September 17
- October (12-)15: Day 210 Opinion by EMA / recommendation of approval
- December 21: Commission Decision / formal approval (based on Day 210 Opinion by EMA, November 12)

*clock restart
** This timetable is only used exceptionally and after agreement with the Rapporteurs when minor issues remain which allow the applicant to respond shortly after the CHMP list of questions and the Rapporteurs to assess the responses within a shortened assessment time.

Check the sticky from Hgd for Europe time table

I am. But with marjac participating

??. Thank You.

I hope you are right. I think this company has very bright future if everything going to go according the plan. I own plenty of shares. Only think that worries me is amount of outstanding shares. Eventually in future they will have to do reverse stock split. I hope they will do it after share price is much higher

If Amrn go genetic they can reduce their overhead. I don’t think they will need all those sales representatives.

Today Pfizer announced that vaccines might be available by the end of the year. On Bloomberg news

Sorry can’t answer privately. But I agree. And how north pointed out generics will not enter anytime soon so Amrn should use the option you pointed out in last resort as soon as generics will enter the market. Question is how fast Amrn can change from regular to generic in USA.

I think this most sensible way to go. I agree with you. Everything else if and it’s big if going to work might take many months and years. I have feeling that way amarin going to go in USA. That is only plausible choice left.

It’s there. I just read it

Maybe. But I don’t understand what he trying to accomplish. Maybe he thinks he can intimidate people into selling shares but whoever wanted to sell they sold already.

I don’t understand your obsession with this board. If you don’t own the stock why you keep posting.

I think there is sticky message from HDG which explains timetables for Ema

I just pray that you are right. If they would allow us en blanc I would be extremely excited. Thank You for all your and everyone else DD.

I think we would have more chances if we had 2 to 1. But those so called judges did 3:0. I think they did that so we would not really have too much chances to have en blanc

I agree. I just listened argument and my personal opinion is that Singer did excellent job. I personally think that judges come in already with made up options on this case especially Dyk. What are theirs options I guess we will find out soon

Does anyone know price for treatment? Thank You

Does anyone know price for treat? Thank You

Almost 2 billion

I agree with you. I used to look forward to reading the board. Now it’s just waste of time. Few people dominating with their nonsense messaging. Trying to prove each other wrong. It’s very simple. We are investing in stock. If you think you made wrong investment or not happy with company. Sell the stock and move on. Everyone can look smart by looking back. It’s like di&k measuring contests. Everyone trying to prove he has biggest one.

This company was developing this cure since 2006? Why so long. Am I missing something

I thought they have office in Dublin. Maybe I am mistaken

Don’t laugh too hard. You might pee your pants

Sorry to say but anyone who believes Uganda’s or any third world countries statistics then that person believes that there is Santa Claus. People dying there and nobody even knows or cares why.

I don’t think he meant that this message board has nothing to offer. I think what Bouf meant that appeal lawyers can not add anything new to appeal case according to appeal rules.

Judge Du did not care that patent office approved Amrns patents. So why appeal court would care if FDA approves Hikmas generic drug. Do you think that appeals court judges watching or reading what FDA approves or not. Or do you think they care about FDA or shareholders opinions.

Citi Upgrades Amarin Corporation (AMRN) to Buy, Anticipates Strong Sales Growth

February 18, 2020 1:46 AM

Citi analyst Joel Beatty upgraded Amarin Corporation (NASDAQ: AMRN) from Neutral to Buy with a price target of $24.00 (from $27.00).

The analyst comments "We still believe Vascepa sales will accelerate strongly over the next couple years. With AMRN trading ~27% lower since November, we see now as an attractive time to buy. Also, we believe AMRN will likely emerge from the ongoing IP litigation with Vascepa exclusivity largely intact "

Thank You very much.

Hi Pharmdude. If you or anyone else have information regarding legitimate pharmaceutical websites from Canada you can provide I would really appreciate. Thank You.